The Hill – FDA Commissioner Scott Gottlieb is resigning his position effective next month, the Trump administration announced Tuesday. In a note to FDA staff, Gottlieb said he was leaving to spend more time with his family, The Hill report said.
"There's nothing that could pull me away from this role other than the challenge of being apart from my family for these past two years and missing my wife and two young children," he wrote.
Gottlieb’s resignation was unexpected, and his replacement has not been announced. This was Gottlieb’s second stint at FDA. He served as a deputy FDA commissioner under former President George W. Bush before leaving the agency in 2007.
In his resignation letter, Gottlieb listed a host of agency accomplishments under his tenure, including a record number of generic drug approvals. He lavished praise on agency staff for being able to avert drug and device shortages in the aftermath of Hurricane Maria in Puerto Rico.
Read the full story at The Hill.
Latest from Quality Assurance & Food Safety
- Non-GMO Project Launches Non-Ultraprocessed Foods Verification
- FDA to Hold Webinar on Updated ‘Healthy’ Claim
- High-Tech Partnership Creates Natural Blue Color for Greener Tomorrow
- Kraft Heinz Hosts Innovation Challenge for Sustainable Packaging
- FDA Requests Information on Poppy Seeds
- Danone North America Opens Applications for Annual Gut Microbiome, Yogurt and Probiotics Fellowship Grant
- WSDA Confirms First Bird Flu Case in 2025
- Senators Call Out FDA for Proposed Cuts to State, Local Food Safety Programs
